| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 130 |
| 1 | PREDNISONE | 89 |
| 2 | METHOTREXATE SODIUM | 76 |
| 3 | DEXAMETHASONE | 72 |
| 4 | DEXAMETHASONE 1.5 MG | 72 |
| 5 | METHOTREXATE | 72 |
| 6 | PREDNISOLONE | 69 |
| 7 | PREDNISOLONE ORAL | 69 |
| 8 | PREDNISOLONE ORAL SOLUTION | 69 |
| 9 | AZATHIOPRINE | 58 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLOPATADINE HCL | 1 | 0.0027 |
| 1 | EPHEDRINE HYDROCHLORIDE | 1 | 0.0022 |
| 2 | ALEMTUZUMAB | 38 | 0.0020 |
| 3 | AMPICILLIN INJECTION | 13 | 0.0017 |
| 4 | AMPICILLIN | 13 | 0.0016 |
| 5 | ISATUXIMAB | 4 | 0.0007 |
| 6 | AZATHIOPRINE | 58 | 0.0007 |
| 7 | ATOVAQUONE | 5 | 0.0006 |
| 8 | ANAKINRA | 10 | 0.0006 |
| 9 | INFLIXIMAB | 130 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 243 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 156 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 73 |
| 3 | Purine Antimetabolite [EPC] | 58 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 47 |
| 5 | Proteasome Inhibitor [EPC] | 42 |
| 6 | Thalidomide Analog [EPC] | 42 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 38 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 9 | Proton Pump Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 47 | 0.0080 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 38 | 0.0020 |
| 2 | Macrolide Antibacterial [EPC] | 1 | 0.0010 |
| 3 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 10 | 0.0006 |
| 5 | Purine Antimetabolite [EPC] | 58 | 0.0006 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Antimalarial [EPC] | 5 | 0.0005 |
| 8 | Antiprotozoal [EPC] | 5 | 0.0005 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |